Percentage of peripheral CD19+CD24hiCD38hi regulatory B cells in neonatal sepsis patients and its functional implication

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 2374-2378

  Pan, Xiao ^a   Ji, Zuoquan ^b   Xue, Jiang ^c  

^a People's Hospital of Linyi City   (China)

^b Hospital of Shandong Medical College   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

COUP transcription factor II; Immunosuppression; Neonatal alloimmune; Thrombocytopenia; Vestibular neuronitis

Indexed keywords

C REACTIVE PROTEIN; CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; INTERLEUKIN 10; CD19 MOLECULE, HUMAN; CD24 PROTEIN, HUMAN; CD38 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; B LYMPHOCYTE; C REACTIVE PROTEIN ELISA KIT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; INFANT; MALE; NEWBORN SEPSIS; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA; VESTIBULAR NEURONITIS; BLOOD; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY;

ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD38; B-LYMPHOCYTES, REGULATORY; C-REACTIVE PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; MALE; MEMBRANE GLYCOPROTEINS; NEONATAL SEPSIS; STAPHYLOCOCCAL INFECTIONS; THROMBOCYTOPENIA;

EID: 84978035560     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.895421     Document Type: Article

References (26)

1. Guinot PG, Dupont H, Longrois D: Some questioning about the assessment of renal perfusion in sepsis. Crit Care Med, 2015; 43(7): e262–64
2. Sauthoff H, Hay JG: New drug for sepsis on the cheap?. Crit Care Med, 2015; 43(7): 1551–52
3. Higgins TL: Variability in risk-adjusted sepsis mortality: How much is too much?. Crit Care Med, 2015; 43(7): 1530–31
4. Kunsdorf-Wnuk A, Marzec-Lewenstein E, Arct-Danielak D et al: The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases. Med Sci Monit, 2005; 11(8): CS49–55
5. Acosta-Herrera M, Pino-Yanes M, Blanco J et al: Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis. Crit Care, 2015; 19(1): 256
6. Krajčinović SS, Doronjski A, Barišić N et al: Risk factors for neonatal sepsis and method for reduction of blood culture contamination. Malawi Med J, 2015; 27(1): 20–24
7. Chao YH, Wu HP, Wu KH et al: An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One, 2014; 9(10): e110338
8. Cao C, Ma T, Chai YF et al: The role of regulatory T cells in immune dysfunction during sepsis. World J Emerg Med, 2015; 6(1): 5–9
9. Chen K, Zhou QX, Shan HW et al: Prognostic value of CD4(+)CD25(+) Tregs as a valuable biomarker for patients with sepsis in ICU. World J Emerg Med, 2015; 6(1): 40–43
10. Zu H, Li Q, Huang P: Expression of Treg subsets on intestinal T cell immunity and endotoxin translocation in porcine sepsis after severe burns. Cell Biochem Biophys, 2014; 70(3): 1699–704
11. Wei Y, Zheng D, Li X et al: Infusion of dendritic cells carrying donor lymphocytes treated with 8-methoxypsoralen and ultraviolet a light induces CD19(+)IL-10(+) regulatory B cells and promotes skin allograft survival. Transplant Proc, 2014; 46(10): 3641–46
12. Li Q, Guo Z, Xu X et al: Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation. Eur J Immunol, 2008; 38(10): 2751–61
13. Peng G, Wang HY, Peng W et al: Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity, 2007; 27(2): 334–48
14. Flores-Borja F, Bosma A, Ng D et al: CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med, 2013; 5(173): 173ra23
15. Duggal NA, Upton J, Phillips AC et al: An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity. Aging Cell, 2013; 12(5): 873–81
16. Lin W, Jin L, Chen H et al: B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjogren’s syndrome: the similarities and differences. Arthritis Res Ther, 2014; 16(3): R118
17. hinese Medical Sciences Branch Group of Neonatology, Chinese Medical Association Editorial Board of Pediatrics: Neonatal sepsis treatment program. Journal of Pediatrics, 2003; 41(12): 897–99
18. Chen K, Zhou QX, Shan HW et al: Prognostic value of CD4(+)CD25(+) Tregs as a valuable biomarker for patients with sepsis in ICU. World J Emerg Med, 2015; 6(1): 40–43
19. Huang H, Xu R, Lin F et al: High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients. Int J Infect Dis, 2015; 30: 57–63
20. Wan YY: Regulatory T cells: immune suppression and beyond. Cell MolImmunol, 2010; 7(3): 204–10
21. Yao Y, Tu Y, Lu Q: Values of C-reactive protein, percentage of neutrophils and mean platelet volume in early diagnosis of neonatal sepsis. Zhongguo Dang Dai Er Ke Za Zhi, 2015; 17(5): 425–29 [in Chinese]
22. Guo Y, Zhang X, Qin M et al: Changes in peripheral CD19(+)Foxp3(+) and CD19(+)TGFb(+) regulatory B cell populations in rheumatoid arthritis patients with interstitial lung disease. J Thorac Dis, 2015; 7(3): 471–77
23. Cui D, Zhang L, Chen J et al: Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity. Clin Exp Med, 2015; 15(3): 285–92
24. Kim J, Lee HJ, Yoo IS et al: Regulatory B cells are inversely associated with disease activity in rheumatoid arthritis. Yonsei Med J, 2014; 55(5): 1354–58
25. Mauri C, Blair PA: Editorial: regulatory B cells: are we really ready to manipulate them for the benefit of patients with autoimmune diseases?. Arthritis Rheumatol, 2014; 66(8): 1982–83
26. Strom AC, Cross AJ, Cole JE et al: B regulatory cells are increased in hypercholesterolemic mice and protect from lesion development via IL-10. Thromb Haemost, 2015; 114(4): 835–47